adsilico
adsilico

adsilico

DR11Ahrefs DR: 11/100. Bottom 25%. Measured by Ahrefs. Median 44.eDR24Effective DR: 24/100. Bottom 25%. Measured by StartupHub.ai. Median 68.Agent50Agent Readiness: 50/100. Top 25%. Measured by StartupHub.ai. Median 41.Speed96Site Speed: 96/100. Top 25%. Measured by Google PageSpeed. Median 62.

AI-powered simulation technology for assessing medical device performance across diverse virtual patient populations.

2024ActiveLeeds, United Kingdom

About

adsilico is a University of Leeds spinout that develops technology to help medical device manufacturers assess implant performance before progressing to clinical trials. Its Virtual Chimera platform uses generative AI to create virtual hearts and blood vessels from anonymised clinical scans combined with physics-based simulations to show how a device behaves across diverse virtual patient populations. This aims to make device testing safer, faster, and more equitable by reducing reliance on animal experimentation and augmenting human trials.

Key facts

Website
adsilico.uk
Headquarters
Leeds, United Kingdom
Founded
2024
Total funding
$17M (Series A)
Business model
B2B

Funding rounds

Funding rounds raised by adsilico
DateRoundAmountLead investors
26 Oct 2026Series A$13MPXN Ventures
26 Feb 2024Seed$4M

Tech stack

Detected on adsilico.uk, last scanned 26 Oct 2026.

CMS / Builders
Webflow
CDN
Cloudflare
Email provider
Mimecast
Add first review

Frequently asked

Is adsilico trustworthy and reputable?

StartupHub's Data Trust & Reputation score for adsilico is 87 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.

How much funding has adsilico raised?

adsilico has raised a total of $17M in funding. The most recent round on record is Series A.